Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of murine L5178Y lymphoma thymidine kinase mutants for in vitro and in vivo antitumour efficacy evaluation of novel thymidylate synthase inhibitors.

Advances in experimental medicine and biology - 1 Jan 1993

Stephens T C, Smith M N, Waterman S E, McCloskey M L, Jackman A L, Boyle F T

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Survival
Share to Drug Screening Assays, Antitumor
Share to Folic Acid
Share to Folic Acid Antagonists

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mice, Inbred DBA

Share to Quinazolines

Share to Thiophenes

Share to Thymidylate Synthase

Source

Identifiers

PMID: 8304186
DOI: 10.1007/978-1-4615-2960-6_120

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of murine L5178Y lymphoma thymidine kinase mutants for in vitro and in vivo antitumour efficacy evaluation of novel thymidylate synthase inhibitors.PMID 8304186Read ↗

Quantitation of small colony trifluorothymidine-resistant mutants of L5178Y/TK+/- mouse lymphoma cells in RPMI-1640 medium.Semantic proximity Read ↗

Unveiling the oncogenic significance of thymidylate synthase in human cancersSemantic proximity Read ↗

Phase I study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor in patients with refractory solid tumors.Semantic proximity Read ↗

Protection of bone marrow cells from toxicity of chemotherapeutic agents targeted toward thymidylate synthase by transfer of mutant forms of human thymidylate synthase cDNA.Semantic proximity Read ↗

Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogsSemantic proximity Read ↗

Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.Semantic proximity Read ↗

Structure Guided Development of Novel Thymidine Mimetics Targeting <i>Pseudomonas aeruginosa</i> Thymidylate Kinase: From Hit to Lead GenerationSemantic proximity Read ↗

Mutation at the TK locus of mouse lymphoma L5178Y cells by 4CMB, 4HMB and BC.Semantic proximity Read ↗

The mouse lymphoma assay.Semantic proximity Read ↗

FOXM1 inhibitor, Siomycin A, synergizes and restores 5-FU cytotoxicity in human cholangiocarcinoma cell lines via targeting thymidylate synthaseSemantic proximity Read ↗

Phase I, pharmacokinetic and biological correlative study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor, and cisplatin in patients with solid tumors.Semantic proximity Read ↗

Creation and characterization of 5-fluorodeoxyuridine-resistant Arg50 loop mutants of human thymidylate synthase.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.